FKBP51 promotes migration and invasion of papillary thyroid carcinoma through NF-κB-dependent epithelial-to-mesenchymal transition.

Ying Gao,Elham Elamin,Rongfang Zhou,Huili Yan,Shuang Liu,Shengnan Hu,Jing Dong,Muyun Wei,Linying Sun,Yueran Zhao
DOI: https://doi.org/10.3892/ol.2018.9517
2018-01-01
Oncology Letters
Abstract:FK506-binding protein 51 (FKBP51) is a member of the immunophilin family, with relevant roles in multiple signaling pathways, tumorigenesis and chemoresistance. However, the function of FKBP51 in papillary thyroid carcinoma (PTC) remains largely unknown. In the present study, increased FKBP51 expression was detected in PTC tissues as compared with adjacent normal tissues, and the expression level was associated with clinical tumor, node and metastasis stage. Using FKBP51-overexpressing K1 cells and FKBP51-knockdown TPC-1 cells, both human PTC cell lines, it was identified that FKBP51 promoted the migration and invasion of PTC, without affecting cell proliferation. Further investigation revealed that FKBP51 activated the NF-kappa B pathway and epithelial-to-mesenchymal transition (EMT) genes, and EMT was suppressed when NF-kappa B was inhibited. It was also assessed whether FKBP51 promoted the formation of cytoskeleton to promote migration and invasion of PTC using a tubulin tracker; however, no evidence of such an effect was observed. These results suggested that FKBP51 promotes migration and invasion through NF-kappa B-dependent EMT.
What problem does this paper attempt to address?